Hit enter to search or ESC to close
About us
Technology
Pipeline
News
Contact
Investors
Media
MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients
By
mrossetti
February 6, 2019
No Comments
Read
Love
0
Share
Tweet
Share
Next Post
MaaT Pharma Announces Positive DSMB Safety Review and Continuation of its Phase II HERACLES Study in Acute GvHD
Leave a Reply
Cancel Reply
My comment is..
Name
*
Email
*
Website
Save my name, email, and website in this browser for the next time I comment.
About us
Technology
Pipeline
News
Contact
Investors
